Biosimilars Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.

    The worldwide Biosimilars market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.8% during the forecast period.

    This report presents the market size and development trends by detailing the Biosimilars market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Biosimilars market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Biosimilars industry and will help you to build a panoramic view of the industrial development.

    Biosimilars Market, By Type:

    • Injection

    • Tablets

    • Others

    Biosimilars Market, By Application:

    • Ankylosing Spondylitis

    • Tumor

    • Rheumatoid Arthrtis

    • Cardiovascular

    Some of the leading players are as follows:

    • Roche Diagnostics

    • Merck KGaA

    • Teva Pharmaceutical

    • Amgen

    • Celltrion

    • Hospira

    • Sandoz International

    • Biocon

    • Mylan

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilars Market

    • 1.3 Market Segment by Type

      • 1.3.1 Injection

      • 1.3.2 Tablets

      • 1.3.3 Others

    • 1.4 Market Segment by Application

      • 1.4.1 Ankylosing Spondylitis

      • 1.4.2 Tumor

      • 1.4.3 Rheumatoid Arthrtis

      • 1.4.4 Cardiovascular

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Biosimilars Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biosimilars by Major Types

      • 3.4.1 Injection

      • 3.4.2 Tablets

      • 3.4.3 Others

    4 Segmentation of Biosimilars Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biosimilars by Major End-Users

      • 4.4.1 Ankylosing Spondylitis

      • 4.4.2 Tumor

      • 4.4.3 Rheumatoid Arthrtis

      • 4.4.4 Cardiovascular

    5 Market Analysis by Major Regions

    • 5.1 Global Biosimilars Production Analysis by Top Regions

    • 5.2 Global Biosimilars Consumption Analysis by Top Regions

    • 5.3 Global Biosimilars Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Biosimilars Production, Import, Consumption and Export Analysis

    6 Product Circulation of Biosimilars Market among Top Countries

    • 6.1 Top 5 Export Countries in Biosimilars Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Biosimilars Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Biosimilars Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biosimilars Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Biosimilars Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Biosimilars Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Biosimilars Landscape Analysis

    • 7.1 North America Biosimilars Landscape Analysis by Top Countries

      • 7.1.1 United States Biosimilars Market Volume and Growth Rate

      • 7.1.2 Canada Biosimilars Market Volume and Growth Rate

      • 7.1.3 Mexico Biosimilars Market Volume and Growth Rate

    8. Europe Biosimilars Landscape Analysis

    • 8.1 Europe Biosimilars Landscape Analysis by Major Types

    • 8.2 Europe Biosimilars Landscape Analysis by Major End-Users

    • 8.3 Europe Biosimilars Landscape Analysis by Top Countries

      • 8.3.1 Germany Biosimilars Market Volume and Growth Rate

      • 8.3.2 UK Biosimilars Market Volume and Growth Rate

      • 8.3.3 France Biosimilars Market Volume and Growth Rate

      • 8.3.4 Italy Biosimilars Market Volume and Growth Rate

      • 8.3.5 Spain Biosimilars Market Volume and Growth Rate

      • 8.3.6 Belgium Biosimilars Market Volume and Growth Rate

      • 8.3.7 Poland Biosimilars Market Volume and Growth Rate

      • 8.3.8 Russia Biosimilars Market Volume and Growth Rate

      • 8.3.9 Turkey Biosimilars Market Volume and Growth Rate

      • 8.3.10 Netherlands Biosimilars Market Volume and Growth Rate

      • 8.3.11 Portugal Biosimilars Market Volume and Growth Rate

      • 8.3.12 Denmark Biosimilars Market Volume and Growth Rate

      • 8.3.13 Finland Biosimilars Market Volume and Growth Rate

      • 8.3.14 Iceland Biosimilars Market Volume and Growth Rate

      • 8.3.15 Norway Biosimilars Market Volume and Growth Rate

      • 8.3.16 Sweden Biosimilars Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Biosimilars Landscape Analysis

    • 9.1 Asia Pacific Biosimilars Landscape Analysis by Top Countries

      • 9.1.1 China Biosimilars Market Volume and Growth Rate

      • 9.1.2 Japan Biosimilars Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Biosimilars Market Volume and Growth Rate

      • 9.1.4 India Biosimilars Market Volume and Growth Rate

      • 9.1.5 ASEAN Biosimilars Market Volume and Growth Rate

      • 9.1.6 South Korea Biosimilars Market Volume and Growth Rate

    10 LAMEA Biosimilars Landscape Analysis

    • 10.1 LAMEA Biosimilars Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Biosimilars Market Volume and Growth Rate

      • 10.1.2 Brazil Biosimilars Market Volume and Growth Rate

      • 10.1.3 North Africa Biosimilars Market Volume and Growth Rate

      • 10.1.4 South Africa Biosimilars Market Volume and Growth Rate

      • 10.1.5 Argentina Biosimilars Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Roche Diagnostics

      • 11.1.1 Roche Diagnostics Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Merck KGaA

      • 11.2.1 Merck KGaA Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Teva Pharmaceutical

      • 11.3.1 Teva Pharmaceutical Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Amgen

      • 11.4.1 Amgen Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Celltrion

      • 11.5.1 Celltrion Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Hospira

      • 11.6.1 Hospira Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Sandoz International

      • 11.7.1 Sandoz International Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Biocon

      • 11.8.1 Biocon Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Mylan

      • 11.9.1 Mylan Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 84 Figures and 208 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Injection

    • Figure Market Size and Growth Rate of Tablets

    • Figure Market Size and Growth Rate of Others

    • Figure Market Size and Growth Rate of Ankylosing Spondylitis

    • Figure Market Size and Growth Rate of Tumor

    • Figure Market Size and Growth Rate of Rheumatoid Arthrtis

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure North America Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure United States Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure France Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure China Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure India Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biosimilars Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biosimilars

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biosimilars by Different Types from 2014 to 2026

    • Table Consumption Share of Biosimilars by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Injection

    • Figure Market Size and Growth Rate of Tablets

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biosimilars by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biosimilars by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Ankylosing Spondylitis

    • Figure Market Size and Growth Rate of Tumor

    • Figure Market Size and Growth Rate of Rheumatoid Arthrtis

    • Figure Market Size and Growth Rate of Cardiovascular

    • Table Global Biosimilars Production by Major Regions

    • Table Global Biosimilars Production Share by Major Regions

    • Table Global Biosimilars Consumption by Major Regions

    • Table Global Biosimilars Consumption Share by Major Regions

    • Table North America Biosimilars Production, Import, Consumption and Export Analysis

    • Table Europe Biosimilars Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Biosimilars Production, Import, Consumption and Export Analysis

    • Table LAMEA Biosimilars Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biosimilars Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biosimilars Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biosimilars Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biosimilars Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table North America Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Biosimilars Consumption Share by Major Countries in 2014

    • Figure North America Biosimilars Consumption Share by Major Countries in 2018

    • Figure North America Biosimilars Consumption Share by Major Countries in 2026

    • Figure United States Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Biosimilars Consumption by Types from 2014 to 2026

    • Table Europe Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Europe Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Europe Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Europe Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Europe Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure France Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure China Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure India Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics

    • Figure Sales and Growth Rate Analysis of Roche Diagnostics

    • Figure Revenue and Market Share Analysis of Roche Diagnostics

    • Table Product and Service Introduction of Roche Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

    • Figure Sales and Growth Rate Analysis of Merck KGaA

    • Figure Revenue and Market Share Analysis of Merck KGaA

    • Table Product and Service Introduction of Merck KGaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical

    • Table Product and Service Introduction of Teva Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

    • Figure Sales and Growth Rate Analysis of Celltrion

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Product and Service Introduction of Celltrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International

    • Figure Sales and Growth Rate Analysis of Sandoz International

    • Figure Revenue and Market Share Analysis of Sandoz International

    • Table Product and Service Introduction of Sandoz International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.